Targeted Therapy for Advanced Urothelial Cancer of the Bladder: Where Do We Stand?

E-ISSN： 1875-5992|12|9|1081-1087

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.12, Iss.9, 2012-01, pp. : 1081-1087

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intra-Arterial Therapies for Hepatocellular Carcinoma: Where Do We Stand?

By Liapi Eleni

Annals of Surgical Oncology, Vol. 17, Iss. 5, 2010-05 ,pp. : 1234-1246

Springer Publishing Company

Access to resources Recommend Favorite

Targeted therapy in advanced colorectal cancer, an update

By Tol J. Punt C.

Targeted Oncology, Vol. 2, Iss. 3, 2007-07 ,pp. : 165-172

Springer Publishing Company

Access to resources Recommend Favorite

Breast Cancer Risk Assessment Models: Where We Stand and Where We Are Going(

International Journal of Cancer Research and Prevention, Vol. , Iss. , 2017-01 ,pp. : 5-16

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Where Do We Stand? Research and Policy Issues Concerning Inequalities in Health and in Healthcare

By Whitehead Margaret M.

Acta Oncologica, Vol. 38, Iss. 1, 1999-02 ,pp. : 41-50

Informa Healthcare

Access to resources Recommend Favorite

A Systematic Overview of Chemotherapy Effects in Urothelial Bladder Cancer

By Nilsson Sten Ragnhammar Peter Nygren Peter Glimelius Bengt

Acta Oncologica, Vol. 40, Iss. 2-3, 2001-03 ,pp. : 371-390

Informa Healthcare

Access to resources Recommend Favorite